• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非酒精性脂肪性肝病的表观遗传学因素。

Epigenetics factors in nonalcoholic fatty liver disease.

机构信息

School of Medicine, Institute of Medical Research A Lanari, University of Buenos Aires, Buenos Aires, Argentina.

Department of Molecular Genetics and Biology of Complex Diseases, National Scientific and Technical Research Council (Conicet)-university of Buenos Aires. Institute of Medical Research (IDIM).

出版信息

Expert Rev Gastroenterol Hepatol. 2022 Jun;16(6):521-536. doi: 10.1080/17474124.2020.1765772. Epub 2020 Jun 1.

DOI:10.1080/17474124.2020.1765772
PMID:32476509
Abstract

: Fatty liver disease, defined by the presence of liver fat infiltration, is part of a cluster of disorders that occur in the context of metabolic syndrome. Epigenetic factors - defined as stable and heritable changes in gene expression without changes in the DNA sequence - may not only play an important role in the disease development in adulthood, but they may start exerting their influence in the prenatal stage.: By using systems biology approaches, we review the main epigenetic modifications and highlight their likely roles in the pathogenesis of nonalcoholic fatty liver disease.: Knowledge of the mechanisms by which epigenetic modifications participate in complex disorders would not only help scientists find novel therapeutic strategies but could also aid in implementing preventive care measures at gestation.

摘要

: 脂肪性肝病是指肝脏脂肪浸润的存在,它是代谢综合征背景下发生的一系列疾病的一部分。表观遗传因素(定义为基因表达的稳定且可遗传的变化,而 DNA 序列不变)不仅可能在成年期疾病发展中发挥重要作用,而且可能在产前阶段就开始发挥作用。: 通过使用系统生物学方法,我们回顾了主要的表观遗传修饰,并强调了它们在非酒精性脂肪性肝病发病机制中的可能作用。: 了解表观遗传修饰参与复杂疾病的机制不仅有助于科学家寻找新的治疗策略,还可以帮助在妊娠期间实施预防保健措施。

相似文献

1
Epigenetics factors in nonalcoholic fatty liver disease.非酒精性脂肪性肝病的表观遗传学因素。
Expert Rev Gastroenterol Hepatol. 2022 Jun;16(6):521-536. doi: 10.1080/17474124.2020.1765772. Epub 2020 Jun 1.
2
Deciphering the role of epigenetic modifications in fatty liver disease: A systematic review.解析表观遗传修饰在脂肪性肝病中的作用:系统评价。
Eur J Clin Invest. 2021 May;51(5):e13479. doi: 10.1111/eci.13479. Epub 2021 Jan 4.
3
Epigenetic mechanisms underlying the link between non-alcoholic fatty liver diseases and nutrition.非酒精性脂肪性肝病与营养之间联系的表观遗传机制
Nutrients. 2014 Aug 21;6(8):3303-25. doi: 10.3390/nu6083303.
4
Immune-related pathogenesis and therapeutic strategies of nonalcoholic steatohepatitis.非酒精性脂肪性肝炎的免疫相关发病机制和治疗策略。
Arch Pharm Res. 2022 Apr;45(4):229-244. doi: 10.1007/s12272-022-01379-1. Epub 2022 Apr 7.
5
Epigenetics in non-alcoholic fatty liver disease.非酒精性脂肪性肝病中的表观遗传学。
Mol Aspects Med. 2017 Apr;54:78-88. doi: 10.1016/j.mam.2016.11.008. Epub 2016 Nov 23.
6
Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in HIV infection: a metabolic approach of an infectious disease.HIV 感染相关性非酒精性脂肪性肝病和非酒精性脂肪性肝炎:感染性疾病的代谢治疗策略。
Expert Rev Gastroenterol Hepatol. 2019 Jun;13(6):531-540. doi: 10.1080/17474124.2019.1599284. Epub 2019 Apr 3.
7
Molecular Mechanisms: Connections between Nonalcoholic Fatty Liver Disease, Steatohepatitis and Hepatocellular Carcinoma.分子机制:非酒精性脂肪性肝病、脂肪性肝炎和肝细胞癌之间的联系。
Int J Mol Sci. 2020 Feb 23;21(4):1525. doi: 10.3390/ijms21041525.
8
Interplay between early-life malnutrition, epigenetic modulation of the immune function and liver diseases.早期营养不良、免疫功能的表观遗传调控与肝脏疾病之间的相互作用。
Nutr Res Rev. 2019 Jun;32(1):128-145. doi: 10.1017/S0954422418000239. Epub 2019 Feb 1.
9
Metabolic-associated Fatty Liver Disease Regulation through Nutri Epigenetic Methylation.通过营养表观遗传甲基化调节代谢相关脂肪性肝病。
Mini Rev Med Chem. 2023;23(17):1680-1690. doi: 10.2174/1389557523666230130093512.
10
Epigenetic Markers and Microbiota/Metabolite-Induced Epigenetic Modifications in the Pathogenesis of Obesity, Metabolic Syndrome, Type 2 Diabetes, and Non-alcoholic Fatty Liver Disease.肥胖症、代谢综合征、2 型糖尿病和非酒精性脂肪性肝病发病机制中的表观遗传标记物和微生物群/代谢物诱导的表观遗传修饰。
Curr Diab Rep. 2019 May 1;19(6):31. doi: 10.1007/s11892-019-1151-4.

引用本文的文献

1
Rewriting the MASLD-associated hepatocellular carcinoma script: Targeting epigenetics and metabolism.改写与代谢相关脂肪性肝病相关的肝细胞癌脚本:靶向表观遗传学和代谢。
Int J Cancer. 2025 Nov 15;157(10):1991-2003. doi: 10.1002/ijc.70047. Epub 2025 Jul 22.
2
Role of genetic variants and DNA methylation of lipid metabolism-related genes in metabolic dysfunction-associated steatotic liver disease.脂质代谢相关基因的遗传变异和DNA甲基化在代谢功能障碍相关脂肪性肝病中的作用
Front Physiol. 2025 Mar 17;16:1562848. doi: 10.3389/fphys.2025.1562848. eCollection 2025.
3
LncRNA aggravates hepatic steatosis via PPARγ signaling.
长链非编码 RNA 通过过氧化物酶体增殖物激活受体 γ 信号加重肝脂肪变性。
Elife. 2024 Oct 22;13:RP96988. doi: 10.7554/eLife.96988.
4
A complement to epigenetics in metabolic dysfunction-associated steatotic liver disease: Editorial on "DNA methylome analysis reveals epigenetic alteration of complement genes in advanced metabolic dysfunction-associated steatotic liver disease".代谢功能障碍相关脂肪性肝病中表观遗传学的补充:关于“DNA甲基化组分析揭示晚期代谢功能障碍相关脂肪性肝病中补体基因的表观遗传改变”的社论
Clin Mol Hepatol. 2025 Jan;31(1):297-300. doi: 10.3350/cmh.2024.0704. Epub 2024 Aug 27.
5
A High-Fat and High-Fructose Diet Exacerbates Liver Dysfunction by Regulating Sirtuins in a Murine Model.在小鼠模型中,高脂高果糖饮食通过调节沉默信息调节因子加剧肝功能障碍。
Life (Basel). 2024 Jun 5;14(6):729. doi: 10.3390/life14060729.
6
Crosstalk between Epigenetics and Metabolic Reprogramming in Metabolic Dysfunction-Associated Steatotic Liver Disease-Induced Hepatocellular Carcinoma: A New Sight.代谢功能障碍相关脂肪性肝病诱导的肝细胞癌中表观遗传学与代谢重编程之间的串扰:新视角
Metabolites. 2024 Jun 8;14(6):325. doi: 10.3390/metabo14060325.
7
The Relationship between Pathogenesis and Possible Treatments for the MASLD-Cirrhosis Spectrum.代谢相关脂肪性肝病-肝硬化谱系的发病机制与可能的治疗方法之间的关系
Int J Mol Sci. 2024 Apr 16;25(8):4397. doi: 10.3390/ijms25084397.
8
Circular RNAs, Noncoding RNAs, and N6-methyladenosine Involved in the Development of MAFLD.参与MAFLD发生发展的环状RNA、非编码RNA和N6-甲基腺苷
Noncoding RNA. 2024 Feb 5;10(1):11. doi: 10.3390/ncrna10010011.
9
Comprehensive analysis of epigenetic and epitranscriptomic genes' expression in human NAFLD.全面分析人类非酒精性脂肪性肝病中表观遗传学和转录后遗传学基因的表达。
J Physiol Biochem. 2023 Nov;79(4):901-924. doi: 10.1007/s13105-023-00976-y. Epub 2023 Aug 25.
10
The intersection between alcohol-related liver disease and nonalcoholic fatty liver disease.酒精性肝病与非酒精性脂肪性肝病的交集。
Nat Rev Gastroenterol Hepatol. 2023 Dec;20(12):764-783. doi: 10.1038/s41575-023-00822-y. Epub 2023 Aug 15.